143 related articles for article (PubMed ID: 14694159)
1. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
J Am Soc Nephrol; 2004 Jan; 15(1):68-78. PubMed ID: 14694159
[TBL] [Abstract][Full Text] [Related]
2. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.
Levidiotis V; Freeman C; Punler M; Martinello P; Creese B; Ferro V; van der Vlag J; Berden JH; Parish CR; Power DA
J Am Soc Nephrol; 2004 Nov; 15(11):2882-92. PubMed ID: 15504941
[TBL] [Abstract][Full Text] [Related]
3. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
4. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of heparanase in puromycin aminonucleoside nephrosis.
Levidiotis V; Kanellis J; Ierino FL; Power DA
Kidney Int; 2001 Oct; 60(4):1287-96. PubMed ID: 11576343
[TBL] [Abstract][Full Text] [Related]
6. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
Miettinen A; Stow JL; Mentone S; Farquhar MG
J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
[TBL] [Abstract][Full Text] [Related]
8. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
9. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
10. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
11. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
13. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
Nakazawa M; Emancipator SN; Lamm ME
J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
[TBL] [Abstract][Full Text] [Related]
15. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
16. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy.
Saran AM; Yuan H; Takeuchi E; McLaughlin M; Salant DJ
Kidney Int; 2003 Dec; 64(6):2072-8. PubMed ID: 14633129
[TBL] [Abstract][Full Text] [Related]
17. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
19. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I.
Makino H; Gibbons JT; Reddy MK; Kanwar YS
J Clin Invest; 1986 Jan; 77(1):142-56. PubMed ID: 2935558
[TBL] [Abstract][Full Text] [Related]
20. Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy.
Szymczak M; Kuźniar J; Kopeć W; Żabińska M; Marchewka Z; Kościelska-Kasprzak K; Klinger M
Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):83-91. PubMed ID: 27091112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
